Integer Holdings Corp.
- ITGR · NYSE
- Electromedical & Electrotherapeutic Apparatus
- Plano, TX
- 11,000 employees
- CIK 0001114483
Updated from SEC filings through
Top things to know
Revenue, FY2025$1.9B+8.0% vs FY2024Operating margin11.9%Operating income $221MEmployees11,000As of December 31, 2025
Next earningsNovember 6, 2026Estimated from past filings
Latest 8-KResults of operations and financial conditionFiled October 29, 2026 Executives
-
Payman Khales President and Chief Executive Officer 8-K, 2026-05-22 -
Diron Smith EVP, Chief Financial Officer 4, 2026-05-12 -
Kirk K. Thor Chief Human Resources Officer 4, 2026-09-16 -
Andrew Senn President, Growth & Innovation 4, 2026-09-10 -
John A. Harris President, Glob Ops & Manu Tec 4, 2026-07-01 -
Jim Stephens President, CRM & Neuro 4, 2026-05-19
Integer Holdings Corp is a U.S. public company in electromedical & electrotherapeutic apparatus (SIC 3845), headquartered in Plano, TX. It trades as ITGR on NYSE. Revenue was $1.9B in the fiscal year ending December 31, 2025, +8.0% from the year before. It reported about 11,000 employees. Payman Khales is President and Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.9B 10-K, 2026-02-23 | $1.7B 10-K, 2026-02-23 | $1.6B 10-K, 2026-02-23 | $1.3B 10-K, 2025-02-20 | $1.2B 10-K, 2024-02-20 |
| Operating income | $221M 10-K, 2026-02-23 | $208M 10-K, 2026-02-23 | $163M 10-K, 2026-02-23 | $113M 10-K, 2025-02-20 | $136M 10-K, 2024-02-20 |
| SG&A | $212M 10-K, 2026-02-23 | $185M 10-K, 2026-02-23 | $173M 10-K, 2026-02-23 | $158M 10-K, 2025-02-20 | $141M 10-K, 2024-02-20 |
| Net income | $103M 10-K, 2026-02-23 | $120M 10-K, 2026-02-23 | $90.7M 10-K, 2026-02-23 | $66.4M 10-K, 2025-02-20 | $96.8M 10-K, 2024-02-20 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Payman Khales President and CEO - Integer Holdings Corporation | President and Chief Executive Officer | 8-K, 2026-05-22 |
| Donald J. Spence | Board member (per proxy) bio: Former President and Chief Executive Officer, Ebb Therapeutics | DEF 14A, 2026-04-06 |
| Michael J. Coyle | Board member (per proxy) bio: Former President and Chief Executive Officer of iRhythm Technologies, Inc. | DEF 14A, 2026-04-06 |
| Diron Smith Chief Financial Officer | EVP, Chief Financial Officer | 4, 2026-05-12 |
| James F. Hinrichs | Board member (per proxy) bio: Chief Financial Officer of Vantive Health, LLC | DEF 14A, 2026-04-06 |
| Kirk K. Thor | Chief Human Resources Officer | 4, 2026-09-16 |
| Andrew Senn | President, Growth & Innovation | 4, 2026-09-10 |
| John A. Harris | President, Glob Ops & Manu Tec | 4, 2026-07-01 |
| Jim Stephens President, Integer Holdings Corporation | President, CRM & Neuro | 4, 2026-05-19 |
| Alvin (Tyrone) Jeffers | Board member (per proxy) bio: Chief Operating Officer, Hillenbrand Inc. | DEF 14A, 2026-04-06 |
| Cheryl C. Capps | Board member (per proxy) bio: Former Senior Vice President and Chief Supply Chain Officer of Corning Inc. | DEF 14A, 2026-04-06 |
| Filippo Passerini | Board member (per proxy) bio: Former Group President and Chief Information Officer, Procter & Gamble Company | DEF 14A, 2026-04-06 |
| James F. Flanagan | Board member (per proxy) bio: Former Chief Operating Officer, PricewaterhouseCoopers, LLP | DEF 14A, 2026-04-06 |
| M. Craig Maxwell | Board member (per proxy) bio: Former Vice President and Chief Technology and Innovation Officer for Parker Hannifin Corporation | DEF 14A, 2026-04-06 |
| Sheila Antrum | Board member (per proxy) bio: Senior Vice President and Chief Operating Officer at UCSF Health | DEF 14A, 2026-04-06 |
| John Harris President Global Operations and Manufacturing Technology Integer Holdings Corp | Executive Vice President, Global Operations and Manufacturing Strategy | 10-K, 2026-02-23 |
What Integer Holdings Corp does
Integer Holdings Corporation, headquartered in Plano, Texas, is one of the world’s largest medical device contract development and manufacturing organizations (“CDMOs”), serving the Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. Our brands include Greatbatch Medical ® and Lake Region Medical ® .
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 34.0 million (as of October 23, 2026) | 10-Q, October 29, 2026 |
|---|---|---|
| Public float | $4.3B (as of June 27, 2025) | 10-K, February 23, 2026 |
| Reportable segments | 1 (period ending October 2, 2026) | 10-Q, October 29, 2026 |
| Latest proxy statement | Meeting April 6, 2026 (filed April 6, 2026) | DEF 14A, April 6, 2026 |
| Auditor | Deloitte & Touche LLP (Williamsville, New York) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| September 15, 2026 | Kirk K. Thor Chief Human Resources Officer | Sale | 31,540 | $4.0M | Form 4, September 16, 2026 |
| September 8, 2026 | Andrew Senn President, Growth & Innovation | Sale | 9,408 | $1.2M | Form 4, September 10, 2026 |
| March 13, 2026 | Tommy P. Thomas VP, Corporate Controller | Sale | 825 | $70K | Form 4, March 17, 2026 |
| November 12, 2025 | John A. Harris EVP, Global Ops and Manufactur | Buy | 1,650 | $116K | Form 4, November 13, 2025 |
| November 11, 2025 | Tommy P. Thomas VP, Corporate Controller | Sale | 884 | $62K | Form 4, November 13, 2025 |
| November 7, 2025 | Diron Smith EVP, Chief Financial Officer | Buy | 1,116 | $75K | Form 4, November 10, 2025 |
| November 6, 2025 | Cheryl C. Capps Director | Buy | 1,600 | $107K | Form 4, November 10, 2025 |
| October 30, 2025 | Payman Khales President & CEO | Buy | 3,127 | $203K | Form 4, October 30, 2025 |
Recent 8-K events
- 8-K filed 2026-10-29
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-21
- Item 5.07 Submission of matters to a vote of security holders
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-14
- Item 8.01 Other events
- 8-K filed 2026-10-02
- Item 8.01 Other events
- 8-K filed 2026-09-30
- Item 8.01 Other events
- 8-K filed 2026-08-04
- Item 1.01 Entry into a material definitive agreement
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2026-08-03
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-03
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-26
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-22
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
Frequently asked questions about Integer Holdings Corp
- What does Integer Holdings Corp do?
- In its own words, from Item 1 of its 10-K: "Integer Holdings Corporation, headquartered in Plano, Texas, is one of the world’s largest medical device contract development and manufacturing organizations (“CDMOs”), serving the Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. Our brands include Greatbatch Medical ® and Lake Region Medical ® ."
- What is Integer Holdings Corp's revenue?
- $1.9B for the fiscal year ending December 31, 2025, from its 10-K filed February 23, 2026.
- Is Integer Holdings Corp profitable?
- Integer Holdings Corp reported net income of $103M for the fiscal year ending December 31, 2025.
- How many employees does Integer Holdings Corp have?
- About 11,000 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Integer Holdings Corp?
- Payman Khales, President and Chief Executive Officer, as named in a 8-K filed May 22, 2026.
- Who is the CFO of Integer Holdings Corp?
- Diron Smith, EVP, Chief Financial Officer, as named in a 4 filed May 12, 2026.
- Where is Integer Holdings Corp headquartered?
- Plano, TX.
- What is Integer Holdings Corp's stock ticker?
- ITGR on NYSE.
- What industry is Integer Holdings Corp in?
- Electromedical & Electrotherapeutic Apparatus, SIC code 3845.
- What is Integer Holdings Corp's website?
- integer.net.
- When does Integer Holdings Corp report earnings next?
- November 6, 2026. This is an estimate from past filing dates, not a confirmed date.
- Is Integer Holdings Corp a public company?
- Yes. Integer Holdings Corp files with the SEC under CIK 0001114483 and trades as ITGR.
- Who audits Integer Holdings Corp?
- Deloitte & Touche LLP, Williamsville, New York, as named in its latest annual report (10-K).
- How many shares of Integer Holdings Corp are outstanding?
- 34.0 million shares as of October 23, 2026, from its 10-Q filed October 29, 2026.
- What is Integer Holdings Corp's public float?
- $4.3B as of June 27, 2025, as reported on the cover of its 10-K filed February 23, 2026.
- How many business segments does Integer Holdings Corp report?
- 1 reportable segment for the period ending October 2, 2026, from its 10-Q filed October 29, 2026.
- When is Integer Holdings Corp's annual shareholder meeting?
- April 6, 2026, per its proxy statement (DEF 14A) filed April 6, 2026.
- Have Integer Holdings Corp insiders traded stock recently?
- Since October 30, 2025, officers and directors reported 4 open-market sales worth about $5.3M and 4 purchases worth about $500K on Forms 4 and 5. The most recent: Kirk K. Thor (Chief Human Resources Officer) sold 31,540 shares on September 15, 2026.